{"id":"W2990253155","doi":"10.1634/theoncologist.2019-0501","title":"Lenvatinib Versus Sorafenib as First-Line Treatment of Unresectable Hepatocellular Carcinoma: A Cost–Utility Analysis","year":2019,"lang":"en","type":"article","venue":"The Oncologist","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Health Science Centre; University of Waterloo","funders":"Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; Ontario Ministry of Research, Innovation and Science","keywords":"Lenvatinib; Sorafenib; Medicine; Hepatocellular carcinoma; Oncology; Internal medicine; Clinical trial","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004431549,0.0003495052,0.001050973,0.0001857381,0.0001640267,0.00002202139,0.0002265866,0.0001944193,0.001947495],"category_scores_gemma":[0.0001100252,0.000215894,0.0007057885,0.001030696,0.0002709842,0.00005885539,0.00007549889,0.0001486916,0.0003809818],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004702627,"about_ca_system_score_gemma":0.0003140608,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004879827,"about_ca_topic_score_gemma":0.0006474943,"domain_scores_codex":[0.9978973,0.0001951117,0.0005218812,0.0005046743,0.0004095776,0.0004715114],"domain_scores_gemma":[0.9976252,0.0006103893,0.0002585235,0.001152489,0.000174342,0.0001790063],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003499177,0.001426291,0.9880076,0.00006711474,0.001826258,0.0001684161,0.0004243231,0.00002609411,0.0005072031,0.0001383916,0.0001429224,0.003766224],"study_design_scores_gemma":[0.0548184,0.04119993,0.5580707,0.00009694787,0.02823051,0.00007666246,0.001518811,0.1145842,0.09854074,0.0004059934,0.1012595,0.001197645],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9799269,0.001684148,0.00004489661,0.001650054,0.0002109279,0.002289813,0.00005871562,0.0000739235,0.01406063],"genre_scores_gemma":[0.9947489,0.0003139818,0.000158052,0.00006323496,0.0001062556,0.0002308853,0.0002765139,0.00002802718,0.004074188],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4299369,"threshold_uncertainty_score":0.9989648,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1282177910948125,"score_gpt":0.3195378907818478,"score_spread":0.1913200996870353,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}